Which hedge funds own KROS? KEROS THERAPEUTICS INC, Q2 2026 13F holders
Healthcare · Open on the interactive board
6 of the hedge funds tracked by WhaleCreep disclosed a position in KROS (KEROS THERAPEUTICS INC) in their Q2 2026 13F filings, worth $13.4m in total. The largest holder by portfolio weight is Renaissance Technologies LLC at 0.0% of its book. 1 manager opened a new position this quarter: Marshall Wace. 2 exited: Brevan Howard Capital Management, Tudor Investment.
6tracked managers holding
1opened this quarter
2exited this quarter
Which hedge funds hold KROS? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| Renaissance Technologies LLC | Q2 2026 | 0.0% | $3.8m | 359,086 | -21% | reduced |
| Citadel Advisors | Q2 2026 | 0.0% | $4.2m | 396,098 | -3% | reduced |
| D. E. Shaw & Co | Q2 2026 | 0.0% | $2.9m | 267,460 | -48% | reduced |
| Millennium Management | Q2 2026 | 0.0% | $2.0m | 184,822 | 73% | added |
| Marshall Wace | Q2 2026 | 0.0% | $370.2k | 34,600 | – | new |
| Point72 Asset Management LP | Q2 2026 | 0.0% | $111.2k | 10,393 | -90% | reduced |
Exited since the previous quarter
| Manager | Prior weight | Prior value |
|---|---|---|
| Brevan Howard Capital Management | 0.0% | $161.7k |
| Tudor Investment | 0.0% | $309.2k |
How has hedge fund ownership of KROS changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 6 | $13.4m |
| Q1 2026 | 7 | $18.0m |
| Q4 2025 | 3 | $13.4m |
| Q3 2025 | 3 | $25.2m |
| Q2 2025 | 2 | $5.7m |
| Q1 2025 | 4 | $15.0m |
| Q4 2024 | 6 | $34.5m |
| Q3 2024 | 7 | $209.1m |
| Q2 2024 | 8 | $130.1m |
| Q1 2024 | 7 | $214.8m |
| Q4 2023 | 5 | $52.4m |
| Q3 2023 | 5 | $47.6m |
| Q2 2023 | 5 | $51.3m |
| Q1 2023 | 6 | $149.3m |
| Q4 2022 | 6 | $160.7m |
| Q3 2022 | 5 | $33.2m |
Counts every tracked manager that disclosed KROS in that quarter's filing, including managers that have since stopped filing.